Jefferies cuts Stryker price target to $440 from $455

Jefferies has adjusted its price target for Stryker Corp. (NYSE:SYK), reducing it to $440 from $455, while maintaining its Buy rating on the stock. The firm cited continued confidence in Stryker’s long-term growth framework and strong fundamentals, including leading player in Healthcare Equipment. Management has emphasized multi-year strategy focused on diversification.

The updated price target reflects 23 times 2027 estimated earnings. Stryker’s recent performance has also drawn attention, with the company reporting strong fourth-quarter 2025 earnings. Organic sales growth reached 11.0%, up from 9.5% in the prior year, and analysts raised or maintained Buy.

Analyst ratings for Stryker remain largely positive, with a consensus rating of "Moderate Buy" based on 23 Wall Street analysts. The average twelve-month price target is $393.39, with Jefferies’ $440 target among the higher estimates. Despite the reduction in its price target, Jefferies remains optimistic about Stryker’s execution and long-term potential (remains optimistic about Stryker).